[131I]Metaiodobenzylguanidine therapy in neural crest tumors: varying outcome in different histopathologies

dc.contributor.authorRachh, S. H.
dc.contributor.authorAbhyankar, S.
dc.contributor.authorBasu, Sandip
dc.date.accessioned2012-03-14T05:14:46Z
dc.date.available2012-03-14T05:14:46Z
dc.date.issued2011
dc.format.extent5478 bytes
dc.format.mimetypetext/html
dc.identifier.sourceNuclear Medicine Communications, 2011. Vol. 32 (12): pp. 1201-1210en
dc.identifier.urihttp://hdl.handle.net/123456789/5870
dc.language.isoenen
dc.subject[131I]metaiodobenzylguanidine (MIBG)en
dc.subjectneural crest tumorsen
dc.subjectneuroblastomaen
dc.subjectparagangliomaen
dc.subjectpheochromocytomaen
dc.subjecttherapyen
dc.title[131I]Metaiodobenzylguanidine therapy in neural crest tumors: varying outcome in different histopathologiesen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0906.htm
Size:
5.35 KB
Format:
Hypertext Markup Language
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections